Omni Bioceuticals

Omni Bioceuticals is a Health Care startup based in the United States, founded in 2014. The company's mission is encapsulated in its slogan, "Make A Difference." Omni Bioceutical Innovations specializes in providing innovative medical-grade skin and hair treatment solutions for the global medical aesthetic market, catering to dermatological and anti-aging needs.

Omni Bioceutical Innovations collaborates with exceptional scientists, forward-thinking physicians, and labs to produce professional-grade products using the highest quality growth factor proteins, amino acids, peptides, and unique formulas. Notably, their patented delivery molecule, M-007, sets their treatments apart by dramatically reducing downtime following ablative procedures, aiding in cellular renewal, encouraging collagen and elastin production, and nourishing hair follicles.

The company's products are tailored to complement medical office aesthetic procedures such as microneedling, fractionated laser treatments, RF lasers, and micro-dermabrasion treatments. Furthermore, Omni offers consulting and collaborative services for Private Label aesthetic product development, leveraging its innovative biotechnology expertise.

Omni Bioceuticals secured a $400.00K Seed Round investment on 10 September 2015. This funding reinforces the company's potential and signifies investor confidence in its vision and capabilities.